Prevalence of sexually transmitted diseases in female athletes in São Paulo, Brazil.

Autor: Araujo MP; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Kleine HT; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Parmigiano TR; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Gomes NT; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Caparroz GP; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Silva ID; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Girão MJ; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Sartori MG; Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Jazyk: angličtina
Zdroj: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2014 Jan-Mar; Vol. 12 (1), pp. 31-5.
DOI: 10.1590/s1679-45082014ao2949
Abstrakt: Objective: To determine the prevalence of sexually transmitted diseases in female athletes.
Methods: An observational, cross-sectional study was conducted including 50 female athletes with mean age of 20 ± 3 years. Colposcopy, pap smear, and polymerase chain reaction for Chlamydia trachomatis, human papillomavirus and Neisseria gonorrhoeae were performed. Blood samples were collected to test for the human immunodeficiency virus, syphilis, hepatitis B and C. The athletes presenting clinical diseases or conditions identifiable by laboratory tests were treated and followed up in the unit.
Results: Forty-six percent of the participants were unaware of sexually transmitted diseases. The prevalence of sexually transmitted diseases among athletes was 48% (24 cases). Human papillomavirus was the most frequent agent (44%). Considering the human papillomavirus genotypes, subtype 16 was the most prevalent (53%), followed by 11-6 (22%) and 18 (13%). Two athletes tested positive for C. trachomatis. There were no cases diagnosed of infection by N. gonorrhoeae, syphilis, hepatitis B, hepatitis C and human immunodeficiency virus. However, only 26 athletes had been vaccinated for hepatitis B.
Conclusion: The prevalence of sexually transmitted diseases in female athletes was high. Primary prevention measures (hepatitis B and human papillomavirus vaccination) and secondary (serology, pap smears) must be offered to this specific group of women. The matter should be further approached in sports.
Databáze: MEDLINE